These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38081104)

  • 21. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of Parkinson's disease.
    Lew M
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):155S-160S. PubMed ID: 18041935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive Study of miRNAs in Parkinson's Disease: Diagnostics and Therapeutic Approaches.
    Owais S; Siddique YH
    CNS Neurol Disord Drug Targets; 2023; 22(3):353-380. PubMed ID: 35021980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic Evaluation of miRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson's Disease.
    Arora T; Sharma G; Prashar V; Singh R; Sharma A; Changotra H; Parkash J
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38823001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology and pathogenesis of Parkinson's disease.
    Olanow CW; Tatton WG
    Annu Rev Neurosci; 1999; 22():123-44. PubMed ID: 10202534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease and pesticides: Are microRNAs the missing link?
    Aloizou AM; Siokas V; Sapouni EM; Sita N; Liampas I; Brotis AG; Rakitskii VN; Burykina TI; Aschner M; Bogdanos DP; Tsatsakis A; Hadjigeorgiou GM; Dardiotis E
    Sci Total Environ; 2020 Nov; 744():140591. PubMed ID: 32721662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.
    Li D; Yang H; Ma J; Luo S; Chen S; Gu Q
    Hum Cell; 2018 Apr; 31(2):106-115. PubMed ID: 29274035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bee venom for the treatment of Parkinson's disease: How far is it possible?
    Awad K; Abushouk AI; AbdelKarim AH; Mohammed M; Negida A; Shalash AS
    Biomed Pharmacother; 2017 Jul; 91():295-302. PubMed ID: 28477460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.
    de Araújo FM; Cuenca-Bermejo L; Fernández-Villalba E; Costa SL; Silva VDA; Herrero MT
    Cell Mol Neurobiol; 2022 Jul; 42(5):1283-1300. PubMed ID: 33387119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
    Pajares M; I Rojo A; Manda G; Boscá L; Cuadrado A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32674367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinson's disease: a short story of 200 years.
    Cuenca L; Gil-Martinez AL; Cano-Fernandez L; Sanchez-Rodrigo C; Estrada C; Fernandez-Villalba E; Herrero MT
    Histol Histopathol; 2019 Jun; 34(6):573-591. PubMed ID: 30540129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?
    Lanore A; Lesage S; Mariani LL; Menon PJ; Ravassard P; Cheval H; Corti O; Brice A; Corvol JC
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease: from genetics to treatments.
    Fan HC; Chen SJ; Harn HJ; Lin SZ
    Cell Transplant; 2013; 22(4):639-52. PubMed ID: 23127617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The central theme of Parkinson's disease: α-synuclein.
    Ozansoy M; Başak AN
    Mol Neurobiol; 2013 Apr; 47(2):460-5. PubMed ID: 23180276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of MicroRNAs in Parkinson's Disease.
    Goh SY; Chao YX; Dheen ST; Tan EK; Tay SS
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31718095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
    Yamashita H; Matsumoto M
    Regen Med; 2007 Jul; 2(4):447-55. PubMed ID: 17635051
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.